Marina Romero‐Ramos

4.4k total citations · 1 hit paper
56 papers, 3.0k citations indexed

About

Marina Romero‐Ramos is a scholar working on Neurology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Marina Romero‐Ramos has authored 56 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Neurology, 32 papers in Cellular and Molecular Neuroscience and 24 papers in Neurology. Recurrent topics in Marina Romero‐Ramos's work include Parkinson's Disease Mechanisms and Treatments (39 papers), Neuroinflammation and Neurodegeneration Mechanisms (23 papers) and Nerve injury and regeneration (19 papers). Marina Romero‐Ramos is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (39 papers), Neuroinflammation and Neurodegeneration Mechanisms (23 papers) and Nerve injury and regeneration (19 papers). Marina Romero‐Ramos collaborates with scholars based in Denmark, Sweden and United States. Marina Romero‐Ramos's co-authors include Vanesa Sánchez-Guajardo, Deniz Kirik, Sara A. Ferreira, Fabia Febbraro, Malú G. Tansey, Ashley S. Harms, Poul Henning Jensen, Christopher J. Barnum, Ayşe Ulusoy and Zuzanna Tracz‐Gaszewska and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Neuroscience.

In The Last Decade

Marina Romero‐Ramos

53 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Periphery and brain, innate and adaptive immunity in Parkinson’s disease

2021 183 citations Ashley S. Harms, Sara A. Ferreira et al. Acta Neuropathologica profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marina Romero‐Ramos Denmark	32	1.8k	1.3k	1.2k	829	605	56	3.0k
Daniel Alvarez‐Fischer Germany	24	1.3k 0.7×	989 0.8×	1.1k 0.9×	904 1.1×	478 0.8×	44	3.1k
Annick Prigent France	13	1.3k 0.7×	905 0.7×	1.0k 0.9×	601 0.7×	464 0.8×	17	2.6k
Pingyi Xu China	32	1.0k 0.6×	1.3k 1.0×	774 0.7×	1.2k 1.4×	510 0.8×	133	3.2k
Sara Hall Sweden	26	1.9k 1.1×	661 0.5×	721 0.6×	517 0.6×	1.1k 1.8×	46	3.1k
Nadia Stefanova Austria	36	3.4k 1.9×	2.1k 1.7×	2.0k 1.7×	1.1k 1.3×	1.2k 2.0×	112	4.9k
Ebba Lohmann Türkiye	26	2.1k 1.1×	1.2k 1.0×	1.0k 0.9×	826 1.0×	801 1.3×	73	3.3k
Ikuko Mizuta Japan	26	891 0.5×	762 0.6×	478 0.4×	736 0.9×	334 0.6×	98	2.0k
Pau Pástor Spain	36	2.2k 1.2×	819 0.6×	790 0.7×	952 1.1×	1.2k 2.0×	123	3.6k
Ashley S. Harms United States	24	1.3k 0.7×	857 0.7×	1.5k 1.3×	764 0.9×	657 1.1×	36	2.8k
Aideen M. Sullivan Ireland	33	965 0.5×	1.5k 1.1×	622 0.5×	1.4k 1.7×	438 0.7×	101	3.5k

Countries citing papers authored by Marina Romero‐Ramos

Since Specialization

Citations

This map shows the geographic impact of Marina Romero‐Ramos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marina Romero‐Ramos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marina Romero‐Ramos more than expected).

Fields of papers citing papers by Marina Romero‐Ramos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marina Romero‐Ramos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marina Romero‐Ramos. The network helps show where Marina Romero‐Ramos may publish in the future.

Co-authorship network of co-authors of Marina Romero‐Ramos

This figure shows the co-authorship network connecting the top 25 collaborators of Marina Romero‐Ramos. A scholar is included among the top collaborators of Marina Romero‐Ramos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marina Romero‐Ramos. Marina Romero‐Ramos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ferreira, Sara A., et al.. (2025). Peripherally administered TNF inhibitor is not protective against α-synuclein-induced dopaminergic neuronal death in rats. Neurobiology of Disease. 206. 106803–106803. 1 indexed citations

Ferreira, Sara A., Nanna Møller Jensen, Mette Richner, et al.. (2025). Bradykinesia and postural instability in a model of prodromal synucleinopathy with α-synuclein aggregation initiated in the gigantocellular nuclei. Acta Neuropathologica Communications. 13(1). 32–32.

Saksida, Tamara, Vladimirs Piļipenko, Marina Romero‐Ramos, et al.. (2025). IMMUnity Unveiled: A Translational NETwork for tackling PARKinson's Disease – IMMUPARKNET. Open Research Europe. 4. 119–119.

Roodveldt, Cintia, Liliana Bernardino, Özgür Öztop Çakmak, et al.. (2024). The immune system in Parkinson's disease: what we know so far. Brain. 147(10). 3306–3324. 41 indexed citations

Romero‐Ramos, Marina, et al.. (2023). The systemic immune response in Parkinson’s disease: focus on the peripheral immune component. Trends in Neurosciences. 46(10). 863–878. 32 indexed citations

Ferreira, Sara A., Conghui Li, Cristine Betzer, et al.. (2023). Sex-dimorphic neuroprotective effect of CD163 in an α-synuclein mouse model of Parkinson’s disease. npj Parkinson s Disease. 9(1). 164–164. 5 indexed citations

Chen, Muwan, Fabia Febbraro, Rachel Kelly, et al.. (2023). Enhanced production of mesencephalic dopaminergic neurons from lineage-restricted human undifferentiated stem cells. Nature Communications. 14(1). 7871–7871. 8 indexed citations

Pavese, Nicola, et al.. (2022). Neuroinflammation and Immune Changes in Prodromal Parkinson’s Disease and Other Synucleinopathies. Journal of Parkinson s Disease. 12(s1). S149–S163. 34 indexed citations

Nissen, Sara Konstantin, Morten Gersel Stokholm, Álex Iranzo, et al.. (2021). Monocyte markers correlate with immune and neuronal brain changes in REM sleep behavior disorder. Proceedings of the National Academy of Sciences. 118(10). 47 indexed citations

10.

Harms, Ashley S., Sara A. Ferreira, & Marina Romero‐Ramos. (2021). Periphery and brain, innate and adaptive immunity in Parkinson’s disease. Acta Neuropathologica. 141(4). 527–545. 183 indexed citations breakdown →

11.

Nissen, Sara Konstantin, Sara A. Ferreira, Marlene Christina Nielsen, et al.. (2020). Soluble CD163 Changes Indicate Monocyte Association With Cognitive Deficits in Parkinson's Disease. Movement Disorders. 36(4). 963–976. 45 indexed citations

12.

Juul‐Madsen, Kristian, Per Qvist, Annette E. Langkilde, et al.. (2020). Size-Selective Phagocytic Clearance of Fibrillar α-Synuclein through Conformational Activation of Complement Receptor 4. The Journal of Immunology. 204(5). 1345–1361. 26 indexed citations

13.

Ferreira, Sara A., Anna C. Schacht, Jan Jacobsen, et al.. (2020). PET imaging reveals early and progressive dopaminergic deficits after intra-striatal injection of preformed alpha-synuclein fibrils in rats. Neurobiology of Disease. 149. 105229–105229. 47 indexed citations

14.

Nissen, Sara Konstantin, Kalpana Shrivastava, Claudia Schulte, et al.. (2019). Alterations in Blood Monocyte Functions in Parkinson's Disease. Movement Disorders. 34(11). 1711–1721. 67 indexed citations

15.

Bez, Francesco, Alexia Polissidis, Werner Poewe, et al.. (2018). Progressive striatonigral degeneration in a transgenic mouse model of multiple system atrophy: translational implications for interventional therapies. Acta Neuropathologica Communications. 6(1). 2–2. 44 indexed citations

16.

Tansey, Malú G. & Marina Romero‐Ramos. (2018). Immune system responses in Parkinson's disease: Early and dynamic. European Journal of Neuroscience. 49(3). 364–383. 113 indexed citations

17.

Jakobsen, Steen, et al.. (2017). Early synaptic dysfunction induced by α-synuclein in a rat model of Parkinson’s disease. Scientific Reports. 7(1). 6363–6363. 66 indexed citations

18.

Etzerodt, Anders, et al.. (2016). Anti-Inflammatory Modulation of Microglia via CD163-Targeted Glucocorticoids Protects Dopaminergic Neurons in the 6-OHDA Parkinson's Disease Model. Journal of Neuroscience. 36(36). 9375–9390. 94 indexed citations

19.

Sánchez-Guajardo, Vanesa, et al.. (2015). The relation between α-synuclein and microglia in Parkinson’s disease: Recent developments. Neuroscience. 302. 47–58. 136 indexed citations

20.

Barkholt, Pernille, Vanesa Sánchez-Guajardo, Deniz Kirik, & Marina Romero‐Ramos. (2012). Long-term polarization of microglia upon α-synuclein overexpression in nonhuman primates. Neuroscience. 208. 85–96. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact